Answers - Finance

In India investors from all over the world are reaping the benefits of its developing stage, consist

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ently growing economy and recent run up in Indian Stocks, Real Estate India. In all this there are s

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ections of investors who are either NRI (Non Resident Indian) or of Indian Origin and they also want

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

to reap the benefit of being Indian or of Indian Origin.

The recent declaration of reforms/ relaxa

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ions for such stream of investors by Indian government are boosting NRIs remittance and Investment i

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

nterest in india.

NRIs want to speculate and are eager to invest in India either because of necessi

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ty or because as their parents or close relatives might live in India and they want to provide them

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

source of monthly income.

Also as a result of NRI repatriation i.e. planning to relocate to India

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

therefore wants to accumulate Indian currency, assets or to diversify the

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

://www.nrirealtynews.com/invest-in-indian-equities.php>portfolio investments India. Others might

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

just be interested in making some quick money through investing in Indian real estate by seeing the

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

quantum leap in prices of Indian real estate.

In the proposed Real Estate Mutual Funds to be launch

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ed, SEBI (Stock Exchange Bureau of India) and Reserve Bank of India will bring forth a blueprint for

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

same in India soon. Moreover REMFs requires a favorable tax system, regulatory and legal system.

P

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

esently for certain classes of domestic investors real estate participation is possible through Vent

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ure capital until REMFs come up full fledged in market to invest.

NRIs are looking forward to inves

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

t in mutual funds as well as REMF (Real Estate Mutual Funds) that would surely give them appreciatio

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

, either in form of Indian currency or source of income to their relatives in India.

In economy out

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

running the other Asian countries as well giving tough competitions to European countries as well in

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

terms of better/ cheap resources, manpower and higher growth it has something for every one to give

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102378/answers-NRI-Investments-In-India.html">NRI Investments In India</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/102378/answers-NRI-Investments-In-India.html]NRI Investments In India[/url]

Power Teams work well when there is an element of trust and integrity. Holding the information for a project is certainly one of those areas where trust is prominent.

Small, medium and large businesses across America have been burdened almost to the point of extinction due to the miss management of our regulatory bodies.

Tags

Links

Answers - NRI Investments In India

Related Articles: